P010 - Dapagliflozina no DM1 - Mônica Gabbay - a podcast by SBD
from 2018-05-14T20:10:12
::
::
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar;38(3):412-9